![Scott Rocklage](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Scott Rocklage
Presidente presso
Halio, Inc.
Profilo
Scott M.
Rocklage is currently the Chairman at Halio, Inc. He is also the Chairman at Aprea Therapeutics AB, Expansion Therapeutics, Inc., and Purigen Biosystems, Inc. Additionally, he serves as a Director at Nouscom AG, NodThera Ltd., Albamunity, Inc., and Nouscom Srl.
He is a Founding Partner at 5AM Venture Management LLC and a Managing Member at 5AM Partners II LLC and 5AM Partners III LLC.
In his former positions, Dr. Rocklage served as the Chairman, President & Chief Executive Officer at Cubist Pharmaceuticals LLC.
He was also the President & Chief Executive Officer at Nycomed Salutar, Inc. from 1986 to 1989.
He held the position of Chief Executive Officer & Independent Director at EPIRUS Biopharmaceuticals, Inc. in 2016.
He served as the Executive Chairman at Miikana Therapeutics, Inc. and Semprus BioSciences Corp.
He was the Executive Chairman & President at Ilypsa, Inc. Dr. Rocklage was the Executive Chairman at Relypsa, Inc. from 2010 to 2014.
He served as the Chairman at Novira Therapeutics LLC from 2012 to 2015 and at Cidara Therapeutics, Inc. from 2013 to 2019.
He was the Chairman at Aprea Therapeutics, Inc. from 2016 to 2020.
He also served as an Independent Director at Achaogen, Inc. from 2014 to 2015.
In terms of education, Dr. Rocklage holds a doctorate degree from the Massachusetts Institute of Technology and an undergraduate degree from the University of California, Berkeley.
Posizioni attive di Scott Rocklage
| Società | Posizione | Inizio |
|---|---|---|
5AM Venture Management LLC
 5AM Venture Management LLC Investment ManagersFinance 5AM Ventures invests in companies located in the US with an investment size ranging from $20 to $30 million. The firm targets companies operating in the fields of life sciences. It provides financing for early stage and corporate spin-out capital requirements and also makes co-investments. | Investitore di Private Equity | 01/01/2003 |
Halio, Inc.
 Halio, Inc. Industrial SpecialtiesProcess Industries Develops adaptive glass for the commercial, residential and automotive markets | Presidente | - |
5AM Partners II LLC | Corporate Officer/Principal | - |
5AM Partners III LLC | Corporate Officer/Principal | - |
Aprea Therapeutics AB
 Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops novel anticancer compounds | Presidente | 01/06/2017 |
Expansion Therapeutics, Inc.
 Expansion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as drug discovery and development company for RNA-mediated diseases | Presidente | - |
NodThera Ltd.
 NodThera Ltd. BiotechnologyHealth Technology Operates biotechnology company which discovers and develops new treatments for diseases driven by chronic inflammation | Direttore/Membro del Consiglio | - |
Nouscom AG
 Nouscom AG Pharmaceuticals: MajorHealth Technology Operates as an oncology company that develops immunotherapies | Direttore/Membro del Consiglio | - |
Purigen Biosystems, Inc.
 Purigen Biosystems, Inc. BiotechnologyHealth Technology Engages in extracting, enriching and quantifying DNA and RNA from biological samples | Direttore/Membro del Consiglio | - |
| ░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
Precedenti posizioni note di Scott Rocklage
| Società | Posizione | Fine |
|---|---|---|
| ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Scott Rocklage
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
64
Relazioni di 1° grado
32
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 32 |
|---|---|
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of pharmaceutical products | Health Technology |
Pulmatrix Operating Co., Inc.
 Pulmatrix Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for respiratory infectious diseases | Health Technology |
Miikana Therapeutics, Inc.
 Miikana Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for treatment of cancer and inflammatory diseases | Health Technology |
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Operates as a a biopharmaceutical company, which engages in the research, development, and commercialization of antibacterial treatments for multi-drug resistant (MDR) gram-negative infections | Health Technology |
Variation Biotechnologies (US), Inc.
 Variation Biotechnologies (US), Inc. BiotechnologyHealth Technology Develops and manufactures vaccines for infectious diseases | Health Technology |
Semprus BioSciences Corp.
 Semprus BioSciences Corp. Pharmaceuticals: GenericHealth Technology Develops medical devices for anti-microbial coating to reduce bloodstream infections | Health Technology |
Rennovia, Inc.
 Rennovia, Inc. Chemicals: Major DiversifiedProcess Industries Develops and commercializes catalyst and chemical manufacturing technologies | Process Industries |
Halio, Inc.
Halio, Inc. Industrial SpecialtiesProcess Industries Develops adaptive glass for the commercial, residential and automotive markets | Process Industries |
Purigen Biosystems, Inc.
Purigen Biosystems, Inc. BiotechnologyHealth Technology Engages in extracting, enriching and quantifying DNA and RNA from biological samples | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ilypsa, Inc.
 Ilypsa, Inc. BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
5AM Venture Management LLC
5AM Venture Management LLC Investment ManagersFinance 5AM Ventures invests in companies located in the US with an investment size ranging from $20 to $30 million. The firm targets companies operating in the fields of life sciences. It provides financing for early stage and corporate spin-out capital requirements and also makes co-investments. | Finance |
Nycomed Salutar, Inc. | |
5AM Partners II LLC | |
WaveRx, Inc.
 WaveRx, Inc. Hospital/Nursing ManagementHealth Services Develops non-invasive treatments for dermatological disorders | Health Services |
Relypsa, Inc.
 Relypsa, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops non-absorbed polymeric drugs for applications in cardiovascular and renal diseases | Health Technology |
Aprea Therapeutics AB
Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops novel anticancer compounds | Health Technology |
5AM Partners III LLC | |
Novira Therapeutics LLC
 Novira Therapeutics LLC Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Zalicus, Inc.
 Zalicus, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops pharmaceutical products for patients suffering from pain and immuno-inflammatory diseases | Health Technology |
EPIRUS Biopharmaceuticals, Inc. /Old/
 EPIRUS Biopharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops monoclonal antibodies | Health Technology |
Cidara Therapeutics, Inc.
 Cidara Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Engages in the discovery, development, and commercialization of novel anti-infectives | Health Technology |
EPIRUS Biopharmaceuticals, Inc.
 EPIRUS Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes biosimilar monoclonal antibodies | Health Technology |
Pulmatrix, Inc.
 Pulmatrix, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for pulmonary disease | Health Technology |
VBI Vaccines, Inc.
 VBI Vaccines, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Health Technology |
Nouscom AG
Nouscom AG Pharmaceuticals: MajorHealth Technology Operates as an oncology company that develops immunotherapies | Health Technology |
Expansion Therapeutics, Inc.
Expansion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as drug discovery and development company for RNA-mediated diseases | Health Technology |
NodThera Ltd.
NodThera Ltd. BiotechnologyHealth Technology Operates biotechnology company which discovers and develops new treatments for diseases driven by chronic inflammation | Health Technology |
Aprea Therapeutics, Inc.
 Aprea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops novel anticancer compounds | Health Technology |
Albamunity, Inc.
 Albamunity, Inc. Medical DistributorsDistribution Services Provides pharmaceutical services | Distribution Services |
Nouscom Srl
 Nouscom Srl Miscellaneous Commercial ServicesCommercial Services Operates as a next-generation immunotherapy company that develops engineered viral vectored vaccines for treatment of cancer | Commercial Services |
